ARCHIVES

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

Advisors’ Report On Intramural Program To Recommend Restructuring

April 14, 1995

2,000 Breast Cancer Recurrence Biomarker Candidates Discovered

August 31, 2012

Allegations Reflect Misunderstanding, Pan Data Says

August 4, 1989

UNC Lineberger Appoints Two, Zaret Wins Chair At Fox Chase.

February 25, 2000

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

August 18, 1989

ACS Adopts Principles As Basis For Reform Of Health Care System

July 17, 1992